Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04818242 · ClinicalTrials.gov registry record · NA
Dexcom Continuous Glucose Monitoring in Long-term Care
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04818242: Completed NA study, sponsored by Emory University.
NCT04818242 is a NA study that has completed, run by Emory University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04818242, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether the use of Dexcom Continuous Glucose Monitoring with Glucose Telemetry System (CGM-GTS) with hypoglycemia alarm will facilitate diabetes treatment and reduce the risk of hypoglycemia in insulin and non-insulin treated patients with type 2 diabetes (T2D) in long-term care facilities, when compared to standard of care using capillary point of care testing.
Primary Outcome
The number of participants with hypoglycemia detected, where hypoglycemia is defined as blood glucose (BG) of less than 70 mg/dL.
Interventions
- DEVICE Dexcom G6 CGM with GTS
- DIAGNOSTIC_TEST POC Blood Glucose Test + Blinded CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2022-10-21 |
| Phase | NA |
What the finished NCT04818242 record still lists
NCT04818242 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Dexcom G6 CGM with GTS is the first listed.
NCT04818242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04818242 about?
NCT04818242 is a clinical study titled "Dexcom Continuous Glucose Monitoring in Long-term Care". The goal of this study is to determine whether the use of Dexcom Continuous Glucose Monitoring with Glucose Telemetry System (CGM-GTS) with hypoglycemia alarm will facilitate diabetes treatment and reduce the risk of hypoglycemia in insulin and non-insulin treated patients with type 2 diabetes (T2D)...
What is the current status of trial NCT04818242?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-04-19. Estimated completion is 2022-10-21.
What interventions are being tested in trial NCT04818242?
The interventions under investigation include: Dexcom G6 CGM with GTS (DEVICE), POC Blood Glucose Test + Blinded CGM (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04818242?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04818242's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI